Antibody-guided three-step therapy for high grade glioma with yttrium-90 biotin

@article{Paganelli1999AntibodyguidedTT,
  title={Antibody-guided three-step therapy for high grade glioma with yttrium-90 biotin},
  author={Giovanni Paganelli and Chiara Grana and Marco Chinol and Marta Cremonesi and Concetta de Cicco and Filippo G. De Braud and Chris Robertson and Stefano Zurrida and Chiara Casadio and Stefania Zoboli and Antonio G Siccardi and Umberto Veronesi},
  journal={European Journal of Nuclear Medicine},
  year={1999},
  volume={26},
  pages={348-357}
}
While the incidence of brain tumours seems to be increasing, median survival in patients with glioblastoma remains less than 1 year, despite improved diagnostic imaging and neurosurgical techniques, and innovations in treatment. We have developed an avidin-biotin pre-targeting approach for delivering therapeutic radionuclides to gliomas, using anti-tenascin monoclonal antibodies, which seems potentially effective for treating these tumours. We treated 48 eligible patients with histologically… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 64 extracted citations

Advancing role of radiolabeled antibodies in the therapy of cancer

Cancer Immunology, Immunotherapy • 2003
View 4 Excerpts
Highly Influenced

Cherenkov counting of yttrium-90 in the dry state; correlations with phosphorus-32 Cherenkov counting data.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine • 2002
View 2 Excerpts
Highly Influenced

References

Publications referenced by this paper.
Showing 1-10 of 32 references

The pharmacology of pretargeting components: optimizing therapeutic targeting

PL Beaumier, DB Axworthy, AR Fritzberg
Q J Nucl Med1996; • 1996
View 11 Excerpts
Highly Influenced

Pharmacokinetic comparison of direct antibody targeting with pretargeting protocols based on streptavidin-biotin binding.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine • 1995
View 11 Excerpts
Highly Influenced

Pilot therapy trial of CEA positive tumours using a three - step pretargeting approach

G Paganelli, P Magnani, M Chinol
Tum Targ • 1998

Gene therapy for cancer: what have we done and where are we going?

Journal of the National Cancer Institute • 1997
View 1 Excerpt

Optimization of the three - step pretargeting approach for diagnosis and therapy in cancer patients

G Paganelli, M Chinol, C Grana
J Nucl Med • 1995

Similar Papers

Loading similar papers…